Fish oil treatment shows promise for liver disease in kids on IV feeding
NCT ID NCT01194063
First seen Apr 04, 2026 · Last updated May 19, 2026 · Updated 6 times
Summary
This study tested a fish oil emulsion called Omegaven in 36 children with liver disease caused by long-term intravenous (IV) nutrition. The goal was to see if it could improve cholestasis, a condition where bile flow is reduced, by lowering bilirubin levels. Participants were children who depended on IV nutrition and had high bilirubin despite standard treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLESTASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, 96826, United States
Conditions
Explore the condition pages connected to this study.